Müller, MJ; Eich, FX; Regenbogen, B et al.
Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disordersJ Psychopharmacol. Bd. 23. H. 3. 2009 S. 278-286
Waldschmitt, C; Pfuhlmann, B; Hiemke, C
Analysis of multiple antidepressant and antipsychotic drugs including active metabolites in serum of psychiatric patients by LC with column switching and spectrophotometric detectionChromatographia. Bd. 69. H. 9/10. 2009 S. 821-827
Voderholzer, U; Hiemke, C
Angaben zu PsychopharmakaVoderholzer, U., Hohagen, F. (Hrsg). Therapie psychischer Erkrankungen - State of the Art -, Kap. 22. 5. Aufl. München: Elsevier Urban & Fischer 2009
Hiemke, C
Arzneimittelinteraktionen, KurzformSchneider, F. (Hrsg). Klinikmanual Psychiatrie, Psychosomatik und Psychotherapie. Heidelberg: Springer 2009
Tadic, A; Elsäßer, A; Victor, A et al.
Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor (BDNF) gene polymorphisms in Borderline Personality DisorderJ Neural Transm. Bd. 116. 2009 S. 1185-8
Breitling, LP; Dahmen, N; Mittelstrass, K et al.
Association of nicotinic acetylcholine receptor subunit alpha 3 polymorphisms with nicotine dependence in 5500 GermansPHARMACOGENOMICS J. Bd. 9. H. 4. 2009 S. 219-224
Dahmen, N; Tonn, P; Messroghli, L et al.
Basal metabolic rate in narcoleptic patientsSleep. Bd. 32. H. 7. 2009 S. 962-4
Dahmen, N; Ghezel-Ahmadi, D; Engel, A
Blood laboratory findings in patients suffering from self-perceived electromagnetic hypersensitivity (EHS)Bioelectromagnetics. Bd. 30. H. 4. 2009 S. 299-306
Philipsen, A; Feige, B; Hesslinger, B et al.
Borderline typical symptoms in adult patients with attention deficit/hyperactivity disorderADHD Atten Def Hyp Disord. Bd. 1. 2009 S. 11-18
Bohus, M; Lieb, K
Borderline-PersönlichkeitsstörungenVoderholzer, U., Hohagen, F. (Hrsg). Therapie psychischer Erkrankungen - State of the Art -, Kap. 18. 5. Aufl. München: Elsevier Urban & Fischer 2009